HA–CD44 interactions have been shown to be involved in multidrug resistance in breast tumor cells and are linked to a positive feedback circuit involving HA, phosphoinositide 3-kinase (PI3K), and ErbB2 (Ma et al., 2018). The gene discussed is CD44; the disease is breast neoplasm.